---
document_datetime: 2023-09-21 19:11:13
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/scintimun-epar-all-authorised-presentations_en.pdf
document_name: scintimun-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7555755
conversion_datetime: 2025-12-28 08:57:42.463273
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form                     | Route of Administration   | Packaging                                             | Content   | Package size      |
|-----------------|-----------------|------------|-----------------------------------------|---------------------------|-------------------------------------------------------|-----------|-------------------|
| EU/1/09/602/001 | Scintimun       | 1 mg       | Kit for radiopharmaceutical preparation | Intravenous use           | powder: vial (glass) powder for solvent: vial (glass) | 1 mg 3 mg | 1 vial + 1 vial   |
| EU/1/09/602/002 | Scintimun       | 1 mg       | Kit for radiopharmaceutical preparation | Intravenous use           | powder: vial (glass) powder for solvent: vial (glass) | 1 mg 3 mg | 2 vials + 2 vials |